Crsp stock forecast 2025.

CRISPR Therapeutics Stock Up 14.6 %. NASDAQ:CRSP opened at $67.89 on Friday. The company’s 50 day moving average price is $46.64 and its 200-day moving average price is $53.09. CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a ...

Crsp stock forecast 2025. Things To Know About Crsp stock forecast 2025.

Among the leaders in the nascent CRISPR space are biotech stocks like CRISPR Therapeutics, (CRSP 2.88%) Editas Medicine, and Intellia Therapeutics. These companies have pipelines that are jam ...Apr 13, 2022 · Among the leaders in the nascent CRISPR space are biotech stocks like CRISPR Therapeutics, (CRSP 2.88%) Editas Medicine, and Intellia Therapeutics. These companies have pipelines that are jam ... CRISPR Therapeutics last issued its quarterly earnings data on November 6th, 2023. The reported ($1.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.63. CRISPR Therapeutics has generated ($4.47) earnings per share over the last year ( ($4.47) diluted earnings per share).In the last quarter, shares of CRISPR Therapeutics CRSP have gained 24.1% against the industry ’s 3.4% fall. The steep rise in the stock price can be associated with the completion of the ...Price target in 14 days: 89.877 USD. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CRSP …

Find real-time NCLH - Norwegian Cruise Line Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.

The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence.

The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ...Get the latest Crispr Therapeutics AG (CRSP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.If we look at the company’s services, clients and according to stock market experts, 1st tdoc stock forecast 2025 can go up to 170.89 USD and 2nd tdoc stock price target is 192.75 USD in 2025, Teladoc Inc. has divided its services into 6 parts which include guidance and support, expert medical services, mental health services, platform and ...NVTA Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Invitae in the last 3 months. The average price target is $1.41 with a high forecast of $4.00 and a low forecast of $0.40. The average price target represents a 104.59% change from the last price of $0.69.Traders Union experts conducted a comprehensive analysis and predicted that by the end of 2024 Google price will hit $179.92. Google will grow to $200.9 in 2025, $279.67 in 2028 and $348.68 in 2030. Traders Union analysts have prepared a selection of analytical forecasts from top portals for 2024, 2025, 2030.

Target values for the price of one CRISPR Therapeutics share for Jan 2024. The weighted average target price per CRISPR Therapeutics share in Jan 2024 is: 63.59. In Jan, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.790% volatility is expected. Pessimistic target level: 56.98.

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ...

Meta Platforms Inc. () Stock Market info Recommendations: Buy or sell Meta Platforms stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Meta Platforms share forecasts, stock quote and buy / sell signals below.According to present data Meta Platforms's META shares and potentially its market environment have …Find real-time CRSR - Corsair Gaming Inc stock quotes, company profile, news and forecasts from CNN Business. If we look at the company’s services, clients and according to stock market experts, 1st tdoc stock forecast 2025 can go up to 170.89 USD and 2nd tdoc stock price target is 192.75 USD in 2025, Teladoc Inc. has divided its services into 6 parts which include guidance and support, expert medical services, mental health services, platform and ...Meta Platforms Inc. () Stock Market info Recommendations: Buy or sell Meta Platforms stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Meta Platforms share forecasts, stock quote and buy / sell signals below.According to present data Meta Platforms's META shares and potentially its market environment have …CRISPR Therapeutics AG (CRSP) share price prediction for 2023, 2024, 2025, 2026 and 2027. CRSP one year forecast. CRISPR Therapeutics AG stock monthly and weekly ...CRISPR Therapeutics Future Growth Future criteria checks 2/6 CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum …Nov 21, 2023 · The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence.

Find real-time VTRS - Viatris Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 30, 2023 · Teladoc Health Stock Forecast 12-04-2023. Forecast target price for 12-04-2023: $ 18.40. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.308%. Pessimistic target level: 18.09. Optimistic target level: 18.52. Shares of CRISPR Therapeutics ( CRSP -0.74%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ...Nokia will start 2025 at $4.39, then soar to $4.44 within the first six months of the year and finish 2025 at $4.50. That means +15% from today. Nokia Stock Forecast 2030-2034. In this period, the Nokia price would rise from $7.31 to $9.18, which is +26%.Nokia will start 2025 at $4.39, then soar to $4.44 within the first six months of the year and finish 2025 at $4.50. That means +15% from today. Nokia Stock Forecast 2030-2034. In this period, the Nokia price would rise from $7.31 to $9.18, which is +26%.20 stocks of aerospace and defense companies expected to grow sales most quickly through 2025 Sep. 16, 2023 at 9:07 a.m ...NVTA Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Invitae in the last 3 months. The average price target is $1.41 with a high forecast of $4.00 and a low forecast of $0.40. The average price target represents a 104.59% change from the last price of $0.69.

Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions. Price Prediction forecast forCRISPR Therapeutics to November 26, and an in-depth analysis for the week of 19 November to 2 December.

Nov 30, 2023 · Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $89.77. The forecasts range from a low of $42.00 to a high of $220.00. The ... Price target in 14 days: 83.058 USD. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CRSP exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis. Markets. Next reporting date. February 22, 2024. EPS forecast (this quarter) -$1.43. Annual revenue (last year) $52.1M. Annual profit (last year) -$474.2M. Net profit margin.View the latest CRISPR Therapeutics AG (CRSP) stock price, news, historical charts, analyst ratings and financial information from WSJ.About the Microsoft Corp. stock forecast. As of 2023 December 02, Saturday current price of MSFT stock is 374.300$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Microsoft stock price as been showing a rising tendency so we believe that similar market segments …For TELADOC HEALTH INC stock forecast for 2023, 2 predictions are offered for each month of 2023 with average TELADOC HEALTH INC stock forecast of $19.58, a high forecast of $20.12, and a low forecast of $19.04. The average TELADOC HEALTH INC stock forecast 2023 represents a 4.7% increase from the last price of $18.7000007629395.2025 Forecast: (CRSP) for 2023-2027 Updated: October 27, 2023 An Insight into CRISPR Therapeutics AG Ticker: CRSP Sector: Healthcare Closing price of the last …Find real-time CRWD - CrowdStrike Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.Target values for the price of one Lithium Americas share for Nov 2025. The weighted average target price per Lithium Americas share in Nov 2025 is: 7.98. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 26.367% volatility is expected. Pessimistic target level: 6.79. Optimistic target level: 9.23.Sep 30, 2021 · According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Rambus share forecasts, stock quote and buy / sell signals below. According to present data Rambus's RMBS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

Oct 15, 2020 · Palantir Technologies Inc - Class A (PLTR) stock price prediction is 15.953138725275 USD. The Palantir Technologies Inc - Class A stock forecast is 15.953138725275 USD for 2024 December 01, Sunday with technical analysis.

Nov 30, 2023 · Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $89.77. The forecasts range from a low of $42.00 to a high of $220.00. The ... That success has led to dramatic price increases for CRSP stock since going public in 2016. Shares flirted with the $200 level in 2021 during the most recent market peak. They currently trade for ...DUBLIN, Sept. 28, 2020 /PRNewswire/ -- The 'Capacitive Sensor Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2... DUBLIN, Sept. 28, 2020 /PRNewswire/ -- The "Capacitive Sensor Market: Global Industry Tren...The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.AA Stock 12 Months Forecast. $28.05. (6.49% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Alcoa in the last 3 months. The average price target is $28.05 with a high forecast of $41.00 and a low forecast of $14.00. The average price target represents a 6.49% change from the last price of $26.34.The first chart below shows the global market size of CRISPR gene editing in 2019 and a forecast for 2030. The market is set to increase by a mind-boggling 1,179% to reach more than $10 billion by ...The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ...CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP.US updated stock price target summary ... FY 2025. CRSP will ...That success has led to dramatic price increases for CRSP stock since going public in 2016. Shares flirted with the $200 level in 2021 during the most recent market peak. They currently trade for ...The share price of CRISPR Therapeutics AG (CRSP) now. What analysts predict: $88.13. 52-week High/Low: $72 / $37.55. 50/200 Day Moving Average: $45.85 / $51.4. This figure corresponds to the Average Price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the support level today.Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.

Teladoc Health Stock Forecast 11-23-2023. Forecast target price for 11-23-2023: $ 17.85. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.410%. Pessimistic target level: 17.63. Optimistic target level: 18.06.CRISPR Therapeutics AG Stock (CRSP) is expected to reach an average price of $116.58 in 2025, with a high prediction of $154.57 and a low estimate of $78.58. This indicates an +78.88% rise from the last recorded price of $65.17. Teladoc Health Stock Forecast 12-04-2023. Forecast target price for 12-04-2023: $ 18.40. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.308%. Pessimistic target level: 18.09. Optimistic target level: 18.52.Instagram:https://instagram. average employer 401k matchbest instrument insurancetop financial advisors in illinoisvanguard high yield tax exempt admiral It's being developed as a one-time curative treatment for two blood disorders, sickle cell disease and beta thalassemia. Regulators in the U.S., the U.K., and Europe are reviewing the candidate as ... e8 prop firmicap etf Exela Technologies, Inc. (NASDAQ:XELA) issued its quarterly earnings results on Friday, November, 5th. The company reported ($1,080.00) earnings per share for the quarter, missing the consensus estimate of ($680.00) by $400.00. The business had revenue of $279.23 million for the quarter, compared to analysts' expectations of $310 … delta pilot salaries Wall Street Stock Market & Finance report, prediction for the future: You'll find the Salesforce share forecasts, stock quote and buy / sell signals below. According to present data Salesforce's CRM shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).The Upstart Holdings stock prediction for 2025 is currently $ 64.08, assuming that Upstart Holdings shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 141.45% increase in the UPST stock price.